A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ML / mistletoe lectin

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ML  (>> Co-occurring Abbreviation)
Long Form:   mistletoe lectin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice. GBM, TMZ, VE
2017 Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model. DC
2016 Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells. ---
2011 Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy. ---
2011 Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters. FLS
2008 Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein. Chol, cryo-TEM, DOPC, DPPC, min
2007 A lectin from Chinese mistletoe increases gammadelta T cell-mediated cytotoxicity through induction of caspase-dependent apoptosis. IL, TNF
2006 Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines. PI, VAE, VT
2006 Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects. GM-CSF, IL-5, IQ
10  2006 In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals. IFN, IL, IP, IQ, PBMC, TNF
11  2006 Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador. VA
12  2006 Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador. VT
13  2005 Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. IQ, PBMC
14  2004 A mistletoe lectin (ML-1)-containing diet reduces the viability of a murine non-Hodgkin lymphoma tumor. LA, NHL, NMRI, USA
15  2004 Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. OVA
16  2004 The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial. GLQ-8, QOL
17  2003 No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro. ADR, AME, IC50
18  2002 In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals. IP, IQ
19  2001 Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models. AME
20  2001 Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro. AME
21  2001 Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study. AQ, HCV
22  2001 Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin. VA
23  2001 [Frequency of the common cold in healthy subjects during exposure to a lectin-rich and a lectin-poor mistletoe preparation in a randomized, double-blind, placebo-controlled study]. IP, IQ
24  2000 Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice. AME
25  2000 Expression of interleukin-4 in apoptotic cells: stimulation of the type-2 cytokine by different toxins in human peripheral blood mononuclear and tumor cells. IFN, IL, PBMC
26  2000 Intracellular expression of IL-4 and inhibition of IFN-gamma by extracts from European mistletoe is related to induction of apoptosis. ME
27  2000 Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells. VT
28  1999 Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins. ROI
29  1999 Differential binding of toxic lectins from Viscum album L., ML I and ML III, to human lymphocytes. ---
30  1999 Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. VT
31  1999 Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro. BrdU
32  1999 Mistletoe lectin A-chain unfolds during the intracellular transport. ELISA, MLA, monAbs
33  1999 Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes. VT
34  1999 Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes. VT
35  1998 Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L. ROI, VT
36  1998 Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. ---
37  1998 Mistletoe in immunology and the clinic (short review). ---
38  1997 Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts. ---
39  1992 Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. ---
40  1991 Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes; comparison of efficiency and specificity. MLA